This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

PharmAthene, ICX Technologies: Midday Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were moving on above-average volume during Wednesday's session.

PharmAthene (PIP - Get Report) surged by $1.70, or 120.6%, to $3.11 following a report in FedBizOpps that Biomedical Advance Research and Development Authority, or BARDA, will negotiate a contract modification with the company, as PharmAthene's activities were relevant for the expansion of the current development effort under BARDA contract. Volume topped 8.83 million shares, compared to the three-month average daily volume of 212,000 shares.

ICX Technologies (ICXT) jumped by $1.62, or 25.7%, to $7.92 as investors piled into airline security plays following a terrorist's attempt to detonate a homemade explosive device on a Detroit-bound aircraft. Reports that airports will implement new body-scanning security equipment pushed ICX shares higher. Volume topped 3.85 million shares, compared to the 50-day average daily volume of 46,000, according to the Nasdaq.

Similarly, Intellicheck Mobilisa (IDN - Get Report) gained by 28 cents, or 16.1%, to $2.02 after the company issued a press release discussing how its Defense ID access control product could have prevented the terrorist attack on Friday. Steve Williams, chief operating officer of Intellicheck Mobilisa, said Defense ID could have prevented the attack on the Detroit bound plane, since the attempted bomber had identification. Volume topped 314,000 shares, compared to the three-month average daily volume of 27,000.

Cleveland Biolabs (CBLI - Get Report) jumped by 37 cents, or 16.2%, to $2.65 after the company said it has formally entered into a 50/50 joint venture, Incuron, with Bioprocess Capital Ventures, a Russian Federation venture capital fund, to develop its Curaxin compounds for cancer applications. Bioprocess Capital Ventures will contribute approximately $18 million over three payments to support development. Volume topped 200,000 shares, compared to the 50-day average daily volume of 59,000.

-- Written by Robert Holmes in Boston.

Check out all of Wednesday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CBLI $3.55 0.57%
IDN $1.61 1.30%
PIP $1.68 2.44%
AAPL $124.24 0.70%
FB $83.01 0.11%

Markets

DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs